ArticleNeuropsychopharmacology reports2020

Pharmacological characterization of a novel potent, selective, and orally active orexin 2 receptor antagonist, SDM-878.

Shunsuke Maehara et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.